| Year |
Citation |
Score |
| 2022 |
Park B, Sardar Pasha SPB, Sishtla KL, Hartman GD, Qi X, Boulton ME, Corson TW. Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization. International Journal of Molecular Sciences. 23. PMID 36555236 DOI: 10.3390/ijms232415595 |
0.669 |
|
| 2022 |
Jensen NR, Lambert-Cheatham N, Hartman GD, Muniyandi A, Park B, Sishtla K, Corson TW. An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images. Methodsx. 9: 101809. PMID 35990811 DOI: 10.1016/j.mex.2022.101809 |
0.576 |
|
| 2022 |
Sishtla K, Lambert-Cheatham N, Lee B, Han DH, Park J, Sardar Pasha SPB, Lee S, Kwon S, Muniyandi A, Park B, Odell N, Waller S, Park IY, Lee SJ, Seo SY, et al. Small-molecule inhibitors of ferrochelatase are antiangiogenic agents. Cell Chemical Biology. PMID 35090600 DOI: 10.1016/j.chembiol.2022.01.001 |
0.651 |
|
| 2021 |
Shetty T, Park B, Corson TW. Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer. Star Protocols. 2: 100533. PMID 34027490 DOI: 10.1016/j.xpro.2021.100533 |
0.671 |
|
| 2021 |
Peng M, Park B, Harikrishnan H, Jahan S, Dai J, Rayana NP, Sugali CK, Sharma TP, Imanishi S, Imanishi Y, Corson TW, Mao W. A smartphone based method for mouse fundus imaging. Experimental Eye Research. 108530. PMID 33675778 DOI: 10.1016/j.exer.2021.108530 |
0.576 |
|
| 2020 |
Shetty T, Sishtla K, Park B, Repass MJ, Corson TW. Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction. Iscience. 23: 101391. PMID 32755804 DOI: 10.1016/J.Isci.2020.101391 |
0.7 |
|
| 2020 |
Barry Z, Park B, Corson TW. Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization. Molecules (Basel, Switzerland). 25. PMID 32751576 DOI: 10.3390/Molecules25153468 |
0.653 |
|
| 2020 |
Merrigan SL, Park B, Ali Z, Jensen LD, Corson TW, Kennedy BN. Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis and . Oncotarget. 11: 493-509. PMID 32082484 DOI: 10.18632/Oncotarget.27380 |
0.607 |
|
| 2019 |
Park B, Corson TW. Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future. Frontiers in Pharmacology. 10: 95. PMID 30792659 DOI: 10.3389/Fphar.2019.00095 |
0.654 |
|
| 2018 |
Sardar Pasha SPB, Sishtla K, Sulaiman RS, Park B, Shetty T, Shah F, Fishel ML, Wikel JH, Kelley MR, Corson TW. Ref-1/APE1 inhibition with novel small molecules blocks ocular neovascularization. The Journal of Pharmacology and Experimental Therapeutics. PMID 30076264 DOI: 10.1124/Jpet.118.248088 |
0.624 |
|
| 2017 |
Sulaiman RS, Park B, Sheik Pran Babu SP, Si Y, Kharwadkar R, Mitter SK, Lee B, Sun W, Qi X, Boulton ME, Meroueh SO, Fei X, Seo SY, Corson TW. Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization. Acs Chemical Biology. PMID 29193961 DOI: 10.1021/Acschembio.7B00854 |
0.73 |
|
| Show low-probability matches. |